The Association of Statin Use and Statin Type and Cognitive Performance: Analysis of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Cardiology

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/clc.20758PMID 20513066PMCID PMC2925406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

  2009cited by this paper
• Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

  2008cited by this paper
• Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort.

  2008cited by this paper
• The Six-Item Screener to detect cognitive impairment in older emergency department patients.

  2008cited by this paper
• Behavioral changes with paranoia in an elderly woman taking atorvastatin.

  2008cited by this paper
• Effects of Simvastatin on Cerebrospinal Fluid Biomarkers and Cognition in Middle-Aged Adults at Risk for Alzheimer's Disease

  2008cited by this paper
• Frequency and course of mild cognitive impairment in a multiethnic community

  2008cited by this paper
• Statins and dementia

  2007cited by this paper
• Association of statin use with cognitive decline in elderly African Americans

  2007cited by this paper
• Reporting participation in epidemiologic studies: a survey of practice.

  2006cited by this paper
• The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design

  2005cited by this paper
• Framingham Stroke Risk Profile and Lowered Cognitive Performance

  2004cited by this paper
• Do statins slow down Alzheimer's disease? A review

  2004cited by this paper
• Cardiovascular Risk Factors and Cognitive Function in Adults 30–59 Years of Age (NHANES III)

  2004cited by this paper
• Effects of hypertension on attention, memory, and executive function in older adults.

  2003cited by this paper
• Prevalence of non-dementing cognitive disturbances and their association with vascular risk factors in an elderly population

  2003cited by this paper
• Cognitive Impairment Associated with Atorvastatin and Simvastatin

  2003cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Six-Item Screener to Identify Cognitive Impairment Among Potential Subjects for Clinical Research

  2002cited by this paper
• Simvastatin‐Associated Memory Loss

  2001cited by this paper
• Statins and dementia.

  2001cited by this paper
• Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.

  2001cited by this paper
• Effects of treatment with lovastatin and pravastatin on daytime cognitive performance

  1995cited by this paper
• Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.

  1994cited by this paper
• Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence

  1986cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system

  2024cites this paper
• The Associations of Loneliness and Social Support with Cognitive Impairment among Middle-Aged and Older Individuals with Diabetes

  2023cites this paper
• The Effects of Statins on Cognitive Performance Are Mediated by Low-Density Lipoprotein, C-Reactive Protein, and Blood Glucose Concentrations

  2023cites this paper
• Statins and cognitive decline in the Cardiovascular Health Study: A comparison of different analytical approaches.

  2021cites this paper
• Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?

  2020cites this paper
• Cognitive Function Assessment in Patients on Moderate- or High-Intensity Statin Therapy

  2020cites this paper
• Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke.

  2020cites this paper
• Impact of Statin Use on Dementia Incidence in Elderly Men and Women with Ischemic Heart Disease

  2020cites this paper
• Evaluation of statins impacts on cognitive function among diabetic patients.

  2019cites this paper
• Statins use and risk of dementia

  2018cites this paper
• Association of functional and structural social support with medication adherence among individuals treated for coronary heart disease risk factors: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study

  2018cites this paper
• Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors

  2017cites this paper
• Risk factors for low high-density lipoprotein among Asian Indians in the United States

  2017cites this paper
• PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)

  2017cites this paper
• Overcoming Challenges With Statin Therapy

  2016cites this paper
• Statins and Cognitive Side Effects: What Cardiologists Need to Know.

  2016cites this paper
• Remembering Statins: Do Statins Have Adverse Cognitive Effects?

  2016cites this paper
• Statin Use, Ageing, and Cognition: A Review

  2016cites this paper
• Relationship between cognitive impairment and hypercholesterolemia in elderly patients with white matter lesions

  2016cites this paper
• Persistence , Putative Adverse Effects , Health Beliefs , and Package Inserts

  2016cites this paper
• ISCHEMIC HEART DISEASE ( D MUKHERJEE , SECTION EDITOR ) Statins and Cognitive Function : an Updated Review

  2015cites this paper
• Statins and cognitive side effects: what cardiologists need to know.

  2015cites this paper
• Coronary Heart Disease Risk Factors and Outcomes in the Twenty-First Century: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

  2015cites this paper
• An assessment by the Statin Cognitive Safety Task Force: 2014 update.

  2014cites this paper
• Long-Term Statin Use and Dementia Risk in Taiwan

  2014cites this paper
• Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction.

  2014cites this paper
• NLA Task Force on Statin Safety--2014 update.

  2014cites this paper
• Defining risk factors associated with renal and cognitive dysfunction

  2014cites this paper
• Cognitive Effects of Statin Medications

  2014cites this paper
• Neuropsychiatric Adverse Events Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management

  2014cites this paper
• Effect of vitamin D on atorvastatin induced blood sugar changes in Wistar albino rats

  2014cites this paper
• Statin Use and Cognitive Function: Population-Based Observational Study with Long-Term Follow-Up

  2014cites this paper
• Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects.

  2013cites this paper
• Problems and Possible Solutions for Therapy with Statins

  2013cites this paper
• Statin Use in Giant Cell Arteritis: A Retrospective Study

  2013cites this paper
• Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.

  2013cites this paper
• Statins and Cognitive Function

  2013cites this paper
• A review of the potential therapeutic role of statins in the treatment of Alzheimer’s disease: current research and opinion

  2013cites this paper
• Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians – A population with the highest risk of premature coronary artery disease & diabetes

  2013cites this paper
• Not There Yet : Medicare Part D and Elimination of Cardiovascular Medication Usage Socio-Demographic Disparities after Myocardial Infarction

  2013cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Is Statin-Associated Cognitive Impairment Clinically Relevant? A Narrative Review and Clinical Recommendations

  2012cites this paper
• Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.

  2012cites this paper
• The controversies of statin therapy: weighing the evidence.

  2012cites this paper
• Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

  2012cites this paper
• Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction

  2011cites this paper
• Recent Publications on Medications and Pharmacy

  2011cites this paper
• Recent Publications on Medications and Pharmacy

  2011cites this paper
• Lipid-lowering drug therapy in elderly patients.

  2011cites this paper
• Recent Publications on Medications and Pharmacy

  2010cites this paper